CH512497A - Verfahren zur Herstellung von Pyrazinoylguanidinen - Google Patents
Verfahren zur Herstellung von PyrazinoylguanidinenInfo
- Publication number
- CH512497A CH512497A CH518468A CH518468A CH512497A CH 512497 A CH512497 A CH 512497A CH 518468 A CH518468 A CH 518468A CH 518468 A CH518468 A CH 518468A CH 512497 A CH512497 A CH 512497A
- Authority
- CH
- Switzerland
- Prior art keywords
- pyrazinoylguanidines
- preparation
- Prior art date
Links
- WNBSDCKJFDZMHT-UHFFFAOYSA-N n-(diaminomethylidene)pyrazine-2-carboxamide Chemical class NC(N)=NC(=O)C1=CN=CC=N1 WNBSDCKJFDZMHT-UHFFFAOYSA-N 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D241/00—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
- C07D241/02—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings
- C07D241/10—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
- C07D241/14—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D241/24—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D241/26—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals with nitrogen atoms directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CH1580270A CH515250A (de) | 1967-04-13 | 1968-04-08 | Verfahren zur Herstellung von Pyrazincarbonsäureaziden |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US63052167A | 1967-04-13 | 1967-04-13 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CH512497A true CH512497A (de) | 1971-09-15 |
Family
ID=24527511
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CH518468A CH512497A (de) | 1967-04-13 | 1968-04-08 | Verfahren zur Herstellung von Pyrazinoylguanidinen |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US3527758A (en:Method) |
| AT (1) | AT281064B (en:Method) |
| BE (1) | BE713471A (en:Method) |
| CH (1) | CH512497A (en:Method) |
| DE (1) | DE1770174A1 (en:Method) |
| ES (1) | ES352666A1 (en:Method) |
| FR (1) | FR1559541A (en:Method) |
| GB (1) | GB1185408A (en:Method) |
| IE (1) | IE32004B1 (en:Method) |
| IL (1) | IL29735A (en:Method) |
| NL (1) | NL6804247A (en:Method) |
| SE (1) | SE354865B (en:Method) |
Families Citing this family (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4894376A (en) * | 1988-02-26 | 1990-01-16 | Trustees Of The University Of Pennsylvania | Methods of treating diseases characterized by hyperexcitability of neurons |
| TW213903B (en:Method) * | 1991-08-16 | 1993-10-01 | Boehringer Ingelheim Kg | |
| US6858615B2 (en) | 2002-02-19 | 2005-02-22 | Parion Sciences, Inc. | Phenyl guanidine sodium channel blockers |
| US6903105B2 (en) | 2003-02-19 | 2005-06-07 | Parion Sciences, Inc. | Sodium channel blockers |
| EP2617709B8 (en) | 2003-06-26 | 2022-12-21 | Biotron Limited | Guanidine derivatives as antiviral agents |
| KR20060060027A (ko) * | 2003-08-18 | 2006-06-02 | 패리온 사이언스 인코퍼레이티드 | 캡핑된 피라지노일구아니딘 나트륨 채널 차단제 |
| US7745442B2 (en) | 2003-08-20 | 2010-06-29 | Parion Sciences, Inc. | Methods of reducing risk of infection from pathogens |
| US20070099968A1 (en) * | 2004-06-26 | 2007-05-03 | Biotron Limited | Antiviral compounds and methods |
| US7399766B2 (en) * | 2004-08-18 | 2008-07-15 | Parion Sciences, Inc. | Soluble amide & ester pyrazinoylguanidine sodium channel blockers |
| US8247436B2 (en) | 2010-03-19 | 2012-08-21 | Novartis Ag | Pyridine and pyrazine derivative for the treatment of CF |
| AR086745A1 (es) | 2011-06-27 | 2014-01-22 | Parion Sciences Inc | 3,5-diamino-6-cloro-n-(n-(4-(4-(2-(hexil(2,3,4,5,6-pentahidroxihexil)amino)etoxi)fenil)butil)carbamimidoil)pirazina-2-carboxamida |
| HUE032891T2 (hu) | 2012-12-17 | 2017-11-28 | Parion Sciences Inc | Klórpirazin-karboxamid-származékok nem kielégítõ nyálkahártya-hidratáció által elõsegített megbetegedések kezelésére |
| CN104995178B (zh) | 2012-12-17 | 2018-06-26 | 帕里昂科学公司 | 3，5-二氨基-6-氯-n-(n-(4-苯基丁基)甲脒基)吡嗪-2-甲酰胺化合物 |
| US9102633B2 (en) | 2013-12-13 | 2015-08-11 | Parion Sciences, Inc. | Arylalkyl- and aryloxyalkyl-substituted epithelial sodium channel blocking compounds |
-
1967
- 1967-04-13 US US630521A patent/US3527758A/en not_active Expired - Lifetime
-
1968
- 1968-03-26 NL NL6804247A patent/NL6804247A/xx unknown
- 1968-04-01 IL IL29735A patent/IL29735A/xx unknown
- 1968-04-02 IE IE377/68A patent/IE32004B1/xx unknown
- 1968-04-04 SE SE04523/68A patent/SE354865B/xx unknown
- 1968-04-08 AT AT343168A patent/AT281064B/de not_active IP Right Cessation
- 1968-04-08 GB GB06833/68A patent/GB1185408A/en not_active Expired
- 1968-04-08 CH CH518468A patent/CH512497A/de not_active IP Right Cessation
- 1968-04-10 BE BE713471D patent/BE713471A/xx unknown
- 1968-04-10 DE DE19681770174 patent/DE1770174A1/de active Pending
- 1968-04-10 ES ES352666A patent/ES352666A1/es not_active Expired
- 1968-04-12 FR FR1559541D patent/FR1559541A/fr not_active Expired
Also Published As
| Publication number | Publication date |
|---|---|
| NL6804247A (en:Method) | 1968-10-14 |
| BE713471A (en:Method) | 1968-10-10 |
| SE354865B (en:Method) | 1973-03-26 |
| GB1185408A (en) | 1970-03-25 |
| ES352666A1 (es) | 1970-01-01 |
| IE32004B1 (en) | 1973-03-07 |
| IL29735A (en) | 1971-08-25 |
| IE32004L (en) | 1968-10-13 |
| FR1559541A (en:Method) | 1969-03-07 |
| US3527758A (en) | 1970-09-08 |
| DE1770174A1 (de) | 1971-09-23 |
| AT281064B (de) | 1970-05-11 |
| IL29735A0 (en) | 1968-06-20 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AT281778B (de) | Verfahren zur Herstellung von Alk-3-en-1-olen | |
| AT283594B (de) | Verfahren zur Herstellung von 7-Halogen-octopyranosiden | |
| AT279602B (de) | Verfahren zur Herstellung von Pyrrol-3-yl-ketonen | |
| CH504421A (de) | Verfahren zur Herstellung von Bis-thioureido-benzolen | |
| CH499541A (de) | Verfahren zur Herstellung von Pyridyl-benzopyranen | |
| CH502292A (de) | Verfahren zur Herstellung von o-Isopropylaminobenzophenonen | |
| AT283357B (de) | Verfahren zur Herstellung von 2-Aryl-v-triazolen | |
| CH502993A (de) | Verfahren zur Herstellung von Ketonitrilen | |
| CH483425A (de) | Verfahren zur Herstellung von p-Alkoxy-piperidin-amiden | |
| AT278001B (de) | Verfahren zur Herstellung von N-Trityl-imidazolen | |
| CH484930A (de) | Verfahren zur Herstellung von Aryloxazolen | |
| CH512423A (de) | Verfahren zur Herstellung von Naphthylisopropylaminen | |
| AT281420B (de) | Verfahren zur Herstellung von α-Triorganosiloxy-ω-hydroxy-diorganopolysiloxanen | |
| CH510024A (de) | Verfahren zur Herstellung von O-Acylpyridoxalen | |
| CH497438A (de) | Verfahren zur Herstellung von Difluor-s-triazinen | |
| AT280309B (de) | Verfahren zur Herstellung von 3-Methansulfonylphenthiazinen | |
| CH498114A (de) | Verfahren zur Herstellung von 2-N-substituierten 2-Amino-5-nitropyridinen | |
| AT284140B (de) | Verfahren zur Herstellung von Pyrazinamidoguanidinen | |
| CH504394A (de) | Verfahren zur Herstellung von 6-Alkyl-citronellolen | |
| CH503053A (de) | Verfahren zur Herstellung von Alkylsulfonylcobalaminen | |
| CH510694A (de) | Verfahren zur Herstellung von Organofluorsilanen | |
| CH483396A (de) | Verfahren zur Herstellung von 1-Brom-4-acylamino-anthrachinonen | |
| CH496000A (de) | Verfahren zur Herstellung von Benzimidazol-N-Oxyden | |
| CH499492A (de) | Verfahren zur Herstellung von äthinylsubstituierten 1-Phenoxy-2-hydroxy-3-alkylaminopropanen | |
| AT290725B (de) | Verfahren zur Herstellung von α-Phenoxyalkylpenizillin |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PL | Patent ceased |